Authors from Facing Our Risk of Cancer Empowered (FORCE), a nonprofit organization focused on hereditary cancer, discuss the importance of genetic testing, guidelines, and coverage considerations.
A survey of veterans leaving the military in 2016 found that women may be underserved by the Veterans Health Administration and may need housing assistance.
The American Diabetes Association recently recognized the important role that psychosocial care plays in diabetes management. Addressing behavioral health needs at all stages of development in youth with diabetes is critical.
The new Accountable Primary Care Model delivers Triple Aim-like outcomes. This model is empirical, measurable, programmatic, scalable, and transplantable.
Enrollment in managed care among Medicaid enrollees presents challenges to classifying Medicaid coverage in cancer registries.
Description of a program embedding nonlicensed care coordinators in primary care practices including training, interventions, and the effect of the program on emergency department visits.
The authors discuss the wide-reaching impact of legislation spurring the adoption of health information technology and provide an overview of the content found in this special issue.
Patient-centered medical homes in Maryland’s multipayer demonstration disrupted the pattern of recurrently high expenditure among the costliest patients and improved continuity of care.
Modest increases in adherence to medication regimens among Medicare patients with heart failure were associated with lower Medicare spending in 3 major drug classes.
The authors evaluated a new "big data" analytic predictive platform that quickly and accurately analyzes large data sets to identify populations at risk of developing conditions such as metabolic syndrome.
Use of administrative claims data is an innovative way of measuring the effect of continuing medical education on physician practice behavior and patient outcomes.
Health insurance plan type may be an important lever for reducing low-value healthcare use among patients with commercial insurance.
ProvenHealth Navigator, Geisinger's version of advanced patient-centered medical homes, is associated with significant savings in total cost of care over time.
A quarter of opioid recipients with commercial insurance had at least 1 indicator of potential misuse by patients or inappropriate prescription practices by providers.
Value-based insurance design for prescription drug coverage increases drug adherence in patients with chronic disease, though their effect on clinical outcomes and health spending remain uncertain.
This study demonstrates a major influence of prehypertension and hypertension on healthcare costs in a large cohort of children, independent of body mass index.
A cost-utility analysis of a hub-and-spoke telestroke network showed that it was economically dominant over routine care.
An examination of the asthma medication ratio (≥0.50) as an informative metric in program evaluation and for healthcare organizations to measure quality of care provided to patients with asthma.
Evaluation of cancer patients’ quality of life at admission enabled improvement of their satisfaction with received care at discharge.
A chronic disease management company presents promising preliminary results from their remote intensive behavioral counseling intervention, aimed at addressing type 2 diabetes.
This article provides insight on the work of 7 of Project ECHO’s replicating partners from around the world who are implementing the ECHO model to address the knowledge gap that underlies integrated palliative care crisis.
Even when things go well, managing diabetes is not easy. Keeping tabs on this disease 24/7 takes planning, commitment, support, and the right tools. For years, a chief complaint among those living with diabetes has been that managed care nickel-and-dimes people over basic supplies, which are comparatively cheap—things like test strips and sensors for a continuous glucose monitor—but will shell out thousands for dialysis and amputations. In the years ahead, if Congress wants to understand rising costs for end-stage renal disease or an increase in emergency department visits for hypoglycemia, it should look directly to CMS’ foray into competitive bidding for blood glucose test strips.